Value Sense
CMPS
COMPASS Pathways plc (CMPS)
Last Price$3.7(6.6%)
Market Cap$253.4M
Intrinsic value score
N/A
Great
Intrinsic value
N/A
DCF value - N/A Relative value - N/A
Undervalued
N/A
LTM P/E
N/A
Peer set median 17.8x
Discount rate
N/A
CMPS
is 30.5% overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

CMPS Intrinsic value

Key Highlights:
Relative Value vs Current Share Price
As of Mar 03, 2025 CMPS Relative Value is $2.6, which is overvalued by 28.8%, compared to current share price of $3.7.
DCF Value vs Current Share Price
As of Mar 03, 2025 CMPS DCF Value is N/A, which is undervalued by N/A, compared to current share price of $3.7.
Methodology
Price per share, $
CMPS
Intrinsic value$2.6
Overvalued by30.5%
Current share price
3.7
Relative value
2.6
DCF value
not available

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

CMPS Historical Intrinsic Value

Crunching data... Almost there!

CMPS vs Peer Set: Intrinsic Value Comparison

General

Intrinsic Value

Financials

Company name

Undervaluation/Overvaluation

Revenue growth

EPS growth

Net income margin

COMPASS Pathways plc logo
COMPASS Pathways plcCMPS
(30.5%)
N/A
7.4%
N/A
Median Peer Set
7.6%
22.3%
7.2%
Chemed Corporation logo
Chemed CorporationCHE
(32.8%)
6.1%
8.3%
12.0%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
(29.4%)
9.1%
79.5%
6.2%
Encompass Health Corporation logo
Encompass Health CorporationEHC
(27.8%)
11.9%
28.8%
8.5%
The Ensign Group, Inc. logo
The Ensign Group, Inc.ENSG
(26.2%)
14.2%
39.9%
7.0%
HCA Healthcare, Inc. logo
HCA Healthcare, Inc.HCA
18.5%
8.7%
15.7%
8.2%
Acadia Healthcare Company, Inc. logo
Acadia Healthcare Company, Inc.ACHC
39.3%
12.2%
N/A
(0.7%)
Universal Health Services, Inc. logo
Universal Health Services, Inc.UHS
79.6%
6.6%
12.1%
5.0%
DaVita Inc. logo
DaVita Inc.DVA
130.3%
5.6%
44.6%
7.3%
Tenet Healthcare Corporation logo
Tenet Healthcare CorporationTHC
203.6%
0.6%
613.3%
15.5%
Fresenius Medical Care AG & Co. KGaA logo
Fresenius Medical Care AG & Co. KGaAFMS
204.9%
(0.6%)
7.7%
2.8%

Explore more intrinsic value tools hub for CMPS

DCF value calculator
Reverse DCF
Peter Lynch charts
Relative Value
Earnings growth model
Peter Lynch Fair Value
Margin of safety
Ben Graham Fair Value
Earnings Power Value
Discount rate

FAQ

What is COMPASS Pathways plc intrinsic value?

As of Mar 03, 2025, COMPASS Pathways plc Intrinsic Value is $2.6. This suggests it may be overvalued by 30.5% compared to its current price of around $3.7.

What is COMPASS Pathways plc DCF (discounted cash flow) valuation?

As of Mar 03, 2025, COMPASS Pathways plc's Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $3.7, using a discount rate of N/A and terminal growth rate of 3.0%.

Is COMPASS Pathways plc overvalued or undervalued?

COMPASS Pathways plc is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $2.6, compared to a market price of around $3.7. This suggests a potential overvaluation of 30.5%.